AIDSinfo Releases Fact Sheet on Dovato, a New HIV Medication

May 10, 2019

The Food and Drug Administration (FDA) recently approved Dovato, a new antiretroviral medication to treat HIV infection. The two-drug (dolutegravir and lamivudine), fixed-dose combination tablet is approved to treat HIV infection in adults who meet certain requirements, as determined by a health care provider. Dovato is a complete regimen for the treatment of HIV infection and should not be used with other HIV medicines. To learn more about Dovato, please see the AIDSinfo Dovato fact sheet [en español].
Do you want to learn more about HIV medicines? Check out the AIDSinfo FDA-Approved HIV Medicines fact sheet and infographic.

Back to Resources